|
Physicians who prescribe Fen-Phen should
realize the potential of liability exposure for PPH injuries from Fen-Phen.
Physicians and the public should be aware that the combination Fen-Phen
(apart from Redux) is a drug which has not
undergone FDA testing (animal and clinical studies on humans) and
therefore the utmost care and consideration should go into the
decision-making process of whether to prescribe the drug.
After prescribing the drug, physicians must supervise the patient
carefully to determine if there are any developing cardiopulmonary side
effects, to make sure the Fen-Phen drug
therapy is working: weight loss with safety.
Additionally, drug manufacturers can be held responsible for
selling an unsafe drug that cauases PPH cases. This especially
applies to a case like Fen-Phen, when the
manufacturers know that the drug is being used in a manner causing
severe adverse health risks such as cases of PPH. The manufacturer
of a drug is responsible for ensuring that it is safe before it is
prescribed to the public.
Do I have a PPH case? |
 |
